| Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| 3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | European Union | World | Exports | Value (US$) | 29,327,743,146.00 | 27,481,580,139.78 | 31,694,926,332.38 | 36,188,653,593.29 | 36,634,393,948.76 | 46,989,157,369.00 | 60,419,667,452.46 | 71,878,595,713.35 | 79,288,637,795.07 | 113,865,184,133.67 | 110,765,729,263.83 | 108,573,013,591.30 |
| Value Growth, YoY (%) | 18.69 | -6.29 | 15.33 | 14.17 | 1.23 | 28.26 | 28.58 | 18.96 | 10.30 | 43.60 | -2.72 | -1.97 | ||||
| Imports | Value (US$) | 17,781,312,891.00 | 18,786,761,461.47 | 21,334,355,153.11 | 23,914,714,622.45 | 25,656,377,565.71 | 32,579,065,206.34 | 32,772,312,487.51 | 34,401,044,499.45 | 36,772,237,639.76 | 53,612,230,183.70 | 44,126,146,132.18 | 56,403,781,889.31 | |||
| Value Growth, YoY (%) | 3.02 | 5.65 | 13.56 | 12.09 | 7.28 | 26.98 | 0.59 | 4.96 | 6.89 | 45.79 | -17.69 | 27.82 |
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union totalled $ 108 billion in 2023. Sales of commodity group 3002 from European Union decreased by 1.97% in value terms compared to 2022. exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 2.19 billion (cumulative exports of commodity group 3002 from European Union amounted $110 billion in 2022)
Exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" amounted to 3.93% of total exports from European Union (cumulative merchandise exports from European Union totalled $ 2.76 trillion in 2023). The share of commodity group 3002 in total exports from European Union decreased by 0.491 p.p. compared to 2022 (it was 4.42% in 2022 and cumulative exports from European Union were equal to $ 2.5 trillion).
Exports of commodity group 3002 amounted to 38% of total sales of group "" from European Union in 2023 (the value of exports of commodity group from European Union amounted to $283 billion in 2023). The share of exports of commodity group 3002 in sales of commodity group from European Union lowered by 1.81 p.p. compared to 2022 (it was 40% in 2022, and exports of commodity group from European Union were $276 billion).
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union in 2023:
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to European Union totalled $ 56 billion in 2023. Sales of commodity group 3002 to European Union went up by 27% compared to 2022: imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 12.2 billion (the value of imports of commodity group 3002 to European Union was equal to $44 billion in 2022)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 2.07% of total import flow to European Union (in 2023, total imports to European Union amounted to $ 2.71 trillion). The share of commodity group 3002 in total imports to European Union increased by 0.619 p.p. compared to 2022 (it was 1.45% in 2022 and cumulative imports to European Union were equal to $ 3.02 trillion).
Imports of commodity group 3002 reached 49% of total imports of group "" to European Union in 2023 (imports of commodity group to European Union totalled $113 billion in 2023). The share of purchases of commodity group 3002 in total imports of commodity group to European Union increased by 6.36 p.p. compared to 2022 (it was 43% in 2022, and imports of commodity group to European Union accounted for $101 billion).
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of European Union in 2023: